Table 2.

Laboratory measurements⁹

	4 months PTE			2 years PTE
	Cases (N = 52)	Controls (N = 104)	P	Cases (N = 52)	Controls (N = 104)	P
Total Cholesterol (mg/dL)	212 ± 5.4	188 ± 4.2	0.002	206 ± 6.5	196 ± 4.6	0.29
LDL Cholesterol (mg/dL)	130 ± 5.0	116 ± 3.2	0.04	127 ± 5.0	123 ± 3.8	0.64
HDL Cholesterol (mg/dL)	41 ± 1.6	39 ± 1.1	0.47	38 ± 1.6	42 ± 1.2	0.11
Triglycerides (mg/dL)	333 ± 34	281 ± 22	0.25	374 ± 57	279 ± 25	0.12
Glucose (mg/dL)	116 ± 5.1	107 ± 2.6	0.16	115 ± 5.2	102 ± 1.9	0.03
White blood cells/mL	6611 ± 462	5633 ± 189	0.06	6420 ± 430	5790 ± 180	0.20
Platelets (/mL)	231 ± 10	218 ± 6	0.25	213 ± 11	216 ± 6	0.53
CD14+ cells/mL	1200 ± 112	825 ± 78	0.04	1090 ± 104	866 ± 44	0.06
CD4+ T cells/mL	646 ± 45	625 ± 32	0.70	647 ± 59	616 ± 31	0.67
CD8+ T cells/mL	1112 ± 68	1065 ± 51	0.60	1106 ± 81	1099 ± 47	0.94
Prothrombin time (seconds)	12.6 ± 0.1	13.0 ± 0.08	0.04	12.8 ± 0.1	12.7 ± 0.08	0.53
% with macroproteinuria	46.8%	33.7%	0.13	51.3%	37.6%	0.14
HIV-RNA (copies/mL)	2540 ± 1570	13860 ± 3790	0.04	20560 ± 10740	15390 ± 3540	0.34
% undetectable HIV-RNA	59.2%	54.8%	0.61	63.0%	45.6%	0.05
Systolic BP (mmHg)	127 ± 2	128 ± 2	0.41	130 ± 3	127 ± 2	0.10
Diastolic BP (mmHg)	77 ± 1	76 ± 1	0.38	78 ± 1	76 ± 1	0.06

⁹Abbreviations used: PTE – prior to the event, BP – blood pressure